RIGOR AND REPRODUCIBILITY IN RESEARCH GUIDANCE FOR REVIEWERS

Similar documents
Changes to NIH grant applications:

NCCIH Natural Products Technical Assistance Webinar: Exploratory Clinical Trials and Studies of Natural Products

NIH NEW CLINICAL TRIAL REQUIREMENTS AND FORMS-E

Investigator Initiated Study Proposal Form

EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL. PHARMACEUTICAL COMMITTEE 21 October 2015

Checklist for Randomized Controlled Trials. The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews

INTERNATIONAL STANDARD ON ASSURANCE ENGAGEMENTS 3000 ASSURANCE ENGAGEMENTS OTHER THAN AUDITS OR REVIEWS OF HISTORICAL FINANCIAL INFORMATION CONTENTS

Assignment 4: True or Quasi-Experiment

Timing Your Research Career & Publishing Addiction Medicine

CRITICAL THINKING: ASSESSMENT RUBRIC. Preliminary Definitions:

CONSORT 2010 checklist of information to include when reporting a randomised trial*

New NCCIH Funding Opportunities for Natural Product Clinical Trials. May 9, 2017

1. Draft checklist for judging on quality of animal studies (Van der Worp et al., 2010)

Title:Problematic computer gaming, console-gaming, and internet use among adolescents: new measurement tool and association with time use

Treatment of Multiple Sclerosis

Assurance Engagements Other than Audits or Review of Historical Financial Statements

Guidelines for the Ethical Treatment of Animals in Research and Teaching at the University of Münster (WWU)

Competency Rubric Bank for the Sciences (CRBS)

Checklist for Text and Opinion. The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews

AXIS critical Appraisal of cross sectional Studies

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

OCR A-Level Psychology Component 1 Section B Designing an investigation

Critique a Research Article. Aliza Ben-Zacharia DNP, ANP, MSCN Heidi Maloni, PhD, ANP, MSCN

THE COLLEGE OF DENTAL SURGEONS HONG KONG. Regulations. relating to. FCDSHK Intermediate Examination. the Specialty of Family Dentistry

Page 4. Line 7 and 8. Do these stats refer to children worldwide? Please clarify.

Missing data in clinical trials: a data interpretation problem with statistical solutions?

Essentials of Pilot Study Design and Conduct. Kenneth E. Schmader, MD Duke Pepper OAIC Durham VA GRECC Duke University and Durham VA Medical Centers

Nature and significance of the local problem

Checklist for Randomized Controlled Trials. The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews

DESCRIPTION: Percentage of final reports for screening mammograms that are classified as probably benign

BACKGROUND + GENERAL COMMENTS

PCORI Funding Announcement: Assessment of Prevention, Diagnosis, and Treatment Options

Principles of publishing

Re: Docket No. FDA D Presenting Risk Information in Prescription Drug and Medical Device Promotion

Auditing Standards and Practices Council

Medicare Physician Fee Schedule Final Rule for CY 2018 Appropriate Use Criteria for Advanced Diagnostic Imaging Services Summary

Best Practice Title: Reporting Programmatic And Repetitive Noncompliances in NTS and SSIMS

DARPA-BAA Frequently Asked Questions

Other Designs. What Aids Our Causal Arguments? Time Designs Cohort. Time Designs Cross-Sectional

SEMINAR ON SERVICE MARKETING

ROADMAP TO REVIEW THE NUTRITION AND HEALTH CLAIMS REGULATION 1924/2006 Food Supplements Europe Comments

GATE CAT Case Control Studies

Reporting Checklist for Nature Neuroscience

510(k) submissions. Getting US FDA clearance for your device: Improving

Cambridge International AS & A Level Global Perspectives and Research. Component 4

Guidance - IDE Early/Expanded Access for Devices

lab exam lab exam Experimental Design Experimental Design when: Nov 27 - Dec 1 format: length = 1 hour each lab section divided in two

Procedure for the Investigation of Misconduct (Staff) Approved: Version 1.1 (February 2016) Summary

MedicalBiostatistics.com

UC Brain Tumor Center Molecular Therapeutics Pilot Grant Program 2013/2014

Unit 2, Lesson 5: Teacher s Edition 1. Unit 2: Lesson 5 Understanding Vaccine Safety

Daniel T Lackland. Medical University of South Carolina

Which factors hinder good decision making?

COMMENTS. Submitted by The International Pharmaceutical Aerosol Consortium

Reporting Checklist for Nature Neuroscience

GATE CAT Diagnostic Test Accuracy Studies

Comments. Type 2 Diabetes

DESCRIPTION: Percentage of final reports for screening mammograms that are classified as probably benign

Survival Skills for Researchers. Study Design

Basis for Conclusions: ISA 230 (Redrafted), Audit Documentation

Instrument for the assessment of systematic reviews and meta-analysis

This memo includes background of the project, the major themes within the comments, and specific issues that require further CSAC/HITAC action.

Use of Standards in Substantial Equivalence Determinations

BIOLOGY. The range and suitability of the work submitted

How the New NIH Guidelines on Inclusion of Women and Minorities Apply: Efficacy Trials, Effectiveness Trials, and Validity

NCCIH s New Approach to Funding Clinical Trials Informational Webinar. April 18, 2017

NATIONAL QUALITY FORUM

*2) Interprets relevance of context

Science Directorate. November 6, 2000

Standards for the reporting of new Cochrane Intervention Reviews

Experimental Psychology

St. Petersburg College Applied Ethics Program Critical Thinking & Application Paper Fall Session 2010

How Does Analysis of Competing Hypotheses (ACH) Improve Intelligence Analysis?

Reporting Checklist for Nature Neuroscience

Considerations on the statistical methods used to assess carcinogenicity studies of pesticides with emphasis on glyphosate

I can analyze safety and sanitation rules and procedures. I can identify ways to handle, prepare, store and serve food.

Title 1 Descriptive title identifying the study design, population, interventions, and, if applicable, trial acronym

International Framework for Assurance Engagements

Access to clinical trial information and the stockpiling of Tamiflu. Department of Health

Consistency in REC Review

VERDIN MANUSCRIPT REVIEW HISTORY REVISION NOTES FROM AUTHORS (ROUND 2)

The ROBINS-I tool is reproduced from riskofbias.info with the permission of the authors. The tool should not be modified for use.

Author's response to reviews

Webinar 3 Systematic Literature Review: What you Need to Know

Source of effectiveness data The estimate for final outcomes was based on a synthesis of completed studies.

Online Supplementary Material

ANDA Submissions Refuse to Receive for Lack of Proper Justification of Impurity Limits Guidance for Industry

Practical guidance for applicants on the submission of applications on food additives, food enzymes and food flavourings

Estimand in China. - Consensus and Reflection from CCTS-DIA Estimand Workshop. Luyan Dai Regional Head of Biostatistics Asia Boehringer Ingelheim

Karen Johnson, Senior Director, and Shaconna Gorham, Senior Project Manager

Year 8 History. Progression Content and concepts (depth of understanding and. Skills mastery

Reporting Checklist for Nature Neuroscience

About Reading Scientific Studies

CLOSED. PCORI Funding Announcement: Assessment of Prevention, Diagnosis, and Treatment Options

CHAMP: CHecklist for the Appraisal of Moderators and Predictors

10.2 Summary of the Votes and Considerations for Policy

EVMS Authorship Guidelines

PROPOSED LANGUAGE TO REVISE STANDARD 3.04 OF THE ETHICS CODE

IPT ADHERENCE AND QUALITY SCALE

AAOS Appropriate Use Criteria Methodology

Transcription:

RIGOR AND REPRODUCIBILITY IN RESEARCH GUIDANCE FOR REVIEWERS

Rigor and Transparency in Research Goal: To support the highest quality science, public accountability, and social responsibility in the conduct of scientific research. NIH s Rigor and Transparency efforts are intended to clarify expectations and highlight attention to four areas that may need more explicit attention by applicants and reviewers: Scientific premise Scientific rigor Consideration of relevant biological variables, such as sex Authentication of key biological and/or chemical resources

Role of Reviewers To assess the scientific merit of each application based on current best practices in the field. To emphasize longstanding NIH expectations regarding Rigor and Reproducibility. Inform the NIH on rigor and reproducibility. Develop consensus and standards for assessing the four components Scientific premise Scientific rigor Consideration of relevant biological variables, such as sex Authentication of key biological and/or chemical resources May differ for specific fields of research May differ for different study sections

Reviewing Rigor and Transparency of Research Applies to which applications? Where will I find it in the application? Where do I include it in my critique? Addition to review criteria Affect overall impact score? Scientific Premise All Research Strategy (Significance) Significance Is there a strong scientific premise for the project? Yes Scientific Rigor All Research Strategy (Approach) Approach Are there strategies to ensure a robust and unbiased approach? Yes Consideration of Relevant Biological Variables, Such as Sex Projects with vertebrate animals and/or human subjects Research Strategy (Approach) Approach Are adequate plans to address relevant biological variables, such as sex, included for studies in vertebrate animals or human subjects? Yes Authentication of Key Biological and/or Chemical Resources Project involving key biological and/or chemical resources New Attachment Additional review considerations Comment on plans for identifying and ensuring validity of resources. No

Scientific Premise GOAL: Ensure that the underlying scientific foundation of the project concepts, previous work, and data (when relevant) is sound. Reviewers will need to mention in their critiques under SIGNIFICANCE section how strong or weak the scientific premise is by assessing whether the applicant has: Provided sufficient justification for the proposed work. Provided a strong argument for their hypothesis or research project. Cited appropriate published work and/or provided strong preliminary data. Appropriately identified strengths and weaknesses in prior work in the field. Proposed to fill broad gaps in the related research field. OR has the applicant provided justification why this is not possible.

Scientific Rigor GOAL: Ensure a strict application of scientific method that supports robust and unbiased design, analysis, interpretation, and reporting of results, and sufficient information for the study to be assessed and reproduced. Give careful consideration to the methods and issues that matter in your field. Reviewers will need to mention in their critiques under APPROACH how strongly or weakly the scientific rigor has been emphasized in the application by basing their assessment on whether the applicant has: Discussed strategies to ensure a robust and unbiased approach, as appropriate for the work proposed. Provided sufficient information to allow independent confirmation or analysis. Powered the study appropriately or based on reasonable assumptions. Presented plans for handling outliers, unintended consequences, etc. Provided statistical procedures to determine appropriate group sizes, numbers of animals, etc. Presented procedures to ensure independent, blinded measurements. Presented procedures to improve precision and minimize variability. Provided criteria for subject inclusion or exclusion. All possible considerations may or may not be appropriate for the scientific field and research question of every application

Relevant Biological Variables GOAL: Ensure that the research accounts for sex and other relevant biological variables in developing research questions and study designs. The ways in which sex and other biological variables need to be accounted for will differ across research questions and fields of study. Reviewers will need to address in their critiques under APPROACH whether the applicant has provided adequate plans to address relevant biological variables for studies in vertebrate animals or human subjects. Applies broadly to all biological variables relevant to the research such as sex, age, source, weight, or genetic strain or any relevant biological variables that could affect experimental outcome. Specific considerations to assess include: Has the applicant considered biological variables, such as sex, that are relevant to the experimental design? Will relevant biological variables be controlled or factored into the study design appropriately. Consideration of sex is required in all studies involving human subjects or vertebrate animals 7

Sex as a Biological Variable Consideration of sex, included under the umbrella of Relevant Biological Variables, is required in all studies involving human subjects or vertebrate animals. NIH expectations for applicants: If little is known about sex differences, the application should include both sexes. Sufficient numbers should be provided to inform the presence or absence of sex differences. Statistically powered comparisons between sexes may not be warranted. Specific hypotheses about sex differences may not be possible. Findings should be reported separately by sex in progress reports and publications. If sex differences are known not to exist, a strong justification should be provided if the application proposes to study one sex. If sex differences are known, experiments should be designed with appropriate group sizes to detect sex differences. NIH expectations for reviewers: As part of the Consideration of Relevant Biological Variables, assess whether the plans to address sex as a biological variable are adequate (for studies in vertebrate animals or human subjects). If the study involves only one sex, is this justified scientifically? 8 Assess within the context of the research question and current scientific knowledge.

Plan for Resource Authentication GOAL: Ensure processes are in place to identify and regularly validate key resources used in their research and avoid unreliable research as a result of misidentified or contaminated resources. Reviewers will comment on the brief plans proposed for identifying and ensuring the validity of key research resources under new Authentication of Key Biological and/or Chemical Resources section Applies broadly to all key research resources such as cell lines, specialty chemicals, antibodies, biologics or any relevant biological resource that could affect experimental outcome. Adequate authentication of key biological and/or chemical resources used in their research is needed to ensure that the resources are genuine. Rate as acceptable/unacceptable (provide brief explanation if unacceptable) Does not affect criterion scores or overall impact score

Related Review Issues Different research fields may have different best practices and reach different conclusions about scientific premise and rigor. Assess based on best practices in the field. Rigor and transparency considerations also applies to R21, R03, and R15 applications. Since these mechanisms do not require preliminary data and the extent to which approach details can be provided may differ. Reviewers should evaluate the scientific merit of these applications, including rigor and transparency, in light of the goals and reviewer guidelines for these activities. Whether rigor and transparency is embedded in the research plan or presented in a separate section should not matter, reviewers should focus their evaluation on the likely outcome, not grant writing preferences.

Related Review Issues An application that does not include premise, rigor, relevant biological variables, or an authentication plan will proceed to review. Page limits have not changed. Be alert for page limit violations (e.g. inappropriate use of appendices or other application sections). Alert the SRO if you see a potential issue. Page limits, cost and time are not valid reasons to disregard attention to these issues. The elements of rigor and reproducibility are not acceptable postsubmission materials. A weak premise, lack of rigor, etc. does not meet the definition of research misconduct. Scientific justifications may be acceptable in certain circumstances

Additional resources Rigor and Reproducibility in grant applications (OER site): http://grants.nih.gov/reproducibility/index.htm NIH presentation of background and goals of Rigor and Transparency (video) https://grants.nih.gov/reproducibility/module_1/presentation.html Reviewer Guidance on Rigor and Transparency: http://grants.nih.gov/grants/peer/guidelines_general/reviewer_guidance_on_rigor_and_transp arency.pdf Consideration of Sex as a Biological Variable in NIH-funded Research http://orwh.od.nih.gov/sexinscience/overview/pdf/not-od-15-102_guidance.pdf Rigor and transparency do not apply to all applications. See List of Eligible Activity Codes: https://nih-extramural-intranet.od.nih.gov/d/sites/default/files/rigoractivitycodes- 20151006.pdf. Also, certain Funding Opportunity Announcements are exempt from Rigor and Transparency, by request from the ICs. Questions about the NIH policy should be directed to reproducibility@nih.gov